Bis-(3′-5′)-cyclic dimeric GMP (c-di-GMP) is a ubiquitous bacterial second messenger that is involved in the regulation of virulence, cell surface-associated traits and biofilm formation.

The licence enables the Company to support its customers and partners in the fields of cell and gene therapy and vaccine development with GMP-grade synthetic DNA for their clinical programs.

The GMP Validation Program is valued at approximately $4.1 million and is inclusive of the following activities: cell line verification, legacy process verification, GMP scale-up production ...

Quotient Sciences, a CDMO, reports that it has installed Centillion’s™ Biofoundry-in-a-Box (BiaB™), a multi-product GMP platform technology for end-to-end RNA manufacture. BiaB is a modular ...